Aldeyra Therapeutics, Inc. - Common Stock (ALDX)
CUSIP: 01438T106
Q1 2016 13F Holders as of 31 Mar 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,794,743
- Total 13F shares
- 4,372,667
- Share change
- -55,088
- Total reported value
- $18,317,243
- Price per share
- $4.19
- Number of holders
- 26
- Value change
- -$231,292
- Number of buys
- 10
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
2.4%
|
1,437,811
|
$9,748,000 | — | 31 Dec 2015 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.1%
|
1,240,458
|
$8,410,000 | — | 31 Dec 2015 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.2%
|
690,538
|
$4,682,000 | — | 31 Dec 2015 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.4%
|
238,500
|
$1,617,000 | — | 31 Dec 2015 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.24%
|
142,000
|
$963,000 | — | 31 Dec 2015 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.23%
|
135,800
|
$921,000 | — | 31 Dec 2015 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.2%
|
118,340
|
$802,000 | — | 31 Dec 2015 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
110,024
|
$746,000 | — | 31 Dec 2015 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.13%
|
76,000
|
$515,000 | — | 31 Dec 2015 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
68,699
|
$466,000 | — | 31 Dec 2015 | |
| Boxer Capital, LLC |
13F
|
Company |
0.11%
|
63,146
|
$428,000 | — | 31 Dec 2015 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.1%
|
57,500
|
$390,000 | — | 31 Dec 2015 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
22,558
|
$152,000 | — | 31 Dec 2015 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
12,286
|
$83,000 | — | 31 Dec 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
7,222
|
$49,000 | — | 31 Dec 2015 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
2,978
|
$20,000 | — | 31 Dec 2015 | |
| Vantage Investment Advisors, LLC |
13F
|
Company |
0%
|
2,000
|
$14,000 | — | 31 Dec 2015 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
958
|
$6,000 | — | 31 Dec 2015 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
781
|
$5,000 | — | 31 Dec 2015 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
156
|
$1,000 | — | 31 Dec 2015 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q1 2016
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2016 vs Q4 2015 Across Filers
| Investor | Q4 2015 Shares | Q1 2016 Shares | Share Diff | Share Chg % | Q4 2015 Value $ | Q1 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.